Skip to main content
Caplight Logo









Carenostics

Carenostics

Private
Berwyn, PennsylvaniaHealthcare & Life Scienceshttps://www.carenostics.com/

Last Round

Accelerator

Oct 8, 2025

Total Funding Raised

$5.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Carenostics is a healthcare AI company that provides a platform to identify undiagnosed and undertreated chronic disease patients for earlier clinical intervention.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, EHR & EMR, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

clinical decision supportEHR integrationchronic disease managementmedical AIpopulation health managementAI scribehealthcare analyticselectronic health recordsEHRnatural language processingNLPclinical intelligencediagnostic gapSMART-on-FHIRvertical SaaSAI agent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carenostics Comparables

Compare Carenostics with similar companies based on industry and business-model similarity.

Carenostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BerryBoost
81%
Lightbeam Health Solutions
74%
ClosedLoop
72%

Carenostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 8, 2025
SeedSep 14, 2023
Convertible DebtNov 13, 2022

Key People

Founding team and executive leadership

Kanishka Rao

Co-Founder And COO

Founding Team

William Landi

Chief Technology Officer

Executive Team

Carenostics Investors

Notable investors and investment history

Carenostics investors
InvestorRounds
GreatPoint VenturesSeed
M13Seed
GaingelsSeed
Bayer G4AConvertible Debt
Endless Frontier LabsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 17, 2026

    Grew 38% QoQ, from 13 to 18 employees.

  • Jul 23, 2026

    Grew 23% QoQ from 13 to 16 employees.

Carenostics Filings

Explore SEC and related filing metadata, where available.

Carenostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Carenostics's valuation, stock price, and market status.

Is Carenostics a public or private company?

Carenostics is a private company.

What is the current stock price of Carenostics?

Carenostics is a private company with no public stock price. No recent secondary market data is available.

How much is Carenostics worth (valuation)?

Valuation information for Carenostics is not publicly available.

Can I buy Carenostics stock?

Carenostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Carenostics's last funding round?

Carenostics's most recent funding round was Seed on September 14, 2023.

Who are the main investors in Carenostics?

Key investors in Carenostics include M13.

Will Carenostics IPO soon?

No public IPO plans have been announced for Carenostics.

How can I track Carenostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carenostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerwyn, Pennsylvania
Employee Range14
Year Founded2021
Last FundingOct 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?